Biopharma Daily Stock Updates - 02/09/21

$XBI $171.86 -1% 📉


PIPELINE:

$HTBX +50% Positive interim survival data from ongoing HS-110 ph 2 NSCLC trial. source


$RMTI +30% Commercial launch in US of Triferic® AVNU for replacement of iron and maintenance of hemoglobin in patients on hemodialysis. source


$ORTX +14% Positive interim data for OTL-203 in MPS-IH. source


$ELOX +9% Publication of scientific manuscript on ELX-02 in the Journal of Cystic Fibrosis. source


$KALV +114% Phase 2 positive results across all endpoints for KVD900 as an oral on-demand treatment for HAE attacks. source


$IPHA +1% Innate Pharma advances lacutamab clinical development program. source


$AMRN +1% Update on VASCEPA regulatory process in mainland China and Hong Kong. source


$AGEN -1% New clinical response data for AGEN1181. source


FINANCIAL:

$KALV +114% Offering


$ACET -2% Offering


$CDAK -9% Offering


$ONCR +1% Offering



0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE